Epigenetic modulation via the C-terminal tail of H2A.Z.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
24 Oct 2024
Historique:
received: 08 07 2022
accepted: 12 10 2024
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

H2A.Z-nucleosomes are present in both euchromatin and heterochromatin and it has proven difficult to interpret their disparate roles in the context of their stability features. Using an in situ assay of nucleosome stability and DT40 cells expressing engineered forms of the histone variant we show that native H2A.Z, but not C-terminally truncated H2A.Z (H2A.Z∆C), is released from nucleosomes of peripheral heterochromatin at unusually high salt concentrations. H2A.Z and H3K9me3 landscapes are reorganized in H2A.Z∆C-nuclei and overall sensitivity of chromatin to nucleases is increased. These tail-dependent differences are recapitulated upon treatment of HeLa nuclei with the H2A.Z-tail-peptide (C9), with MNase sensitivity being increased genome-wide. Fluorescence correlation spectroscopy revealed C9 binding to reconstituted nucleosomes. When introduced into live cells, C9 elicited chromatin reorganization, overall nucleosome destabilization and changes in gene expression. Thus, H2A.Z-nucleosomes influence global chromatin architecture in a tail-dependent manner, what can be modulated by introducing the tail-peptide into live cells.

Identifiants

pubmed: 39448645
doi: 10.1038/s41467-024-53514-9
pii: 10.1038/s41467-024-53514-9
doi:

Substances chimiques

Histones 0
Nucleosomes 0
Heterochromatin 0
Chromatin 0
histone H2A.F-Z 0
Euchromatin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9171

Subventions

Organisme : Nemzeti Kutatási, Fejlesztési és Innovációs Hivatal (NKFI Office)
ID : K138524, K128770
Organisme : European Cooperation in Science and Technology (COST)
ID : CA15214, CA18127
Organisme : EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
ID : no. 739593

Informations de copyright

© 2024. The Author(s).

Références

Kreienbaum, C., Paasche, L. W. & Hake, S. B. H2A.Z’s ‘social’ network: functional partners of an enigmatic histone variant. Trends Biochem. Sci. 47, 909–920 (2022).
pubmed: 35606214 doi: 10.1016/j.tibs.2022.04.014
Colino-Sanguino, Y., Clark, S. J. & Valdes-Mora, F. The H2A.Z-nuclesome code in mammals: emerging functions. Trends Genet.: TIG 38, 273–289 (2022).
pubmed: 34702577 doi: 10.1016/j.tig.2021.10.003
West, M. H. & Bonner, W. M. Histone 2A, a heteromorphous family of eight protein species. Biochemistry 19, 3238–3245 (1980).
pubmed: 7407044 doi: 10.1021/bi00555a022
Bonisch, C. & Hake, S. B. Histone H2A variants in nucleosomes and chromatin: more or less stable? Nucleic Acids Res. 40, 10719–10741 (2012).
pubmed: 23002134 pmcid: 3510494 doi: 10.1093/nar/gks865
Park, Y. J., Dyer, P. N., Tremethick, D. J. & Luger, K. A new fluorescence resonance energy transfer approach demonstrates that the histone variant H2AZ stabilizes the histone octamer within the nucleosome. J. Biol. Chem. 279, 24274–24282 (2004).
pubmed: 15020582 doi: 10.1074/jbc.M313152200
Fan, J. Y., Gordon, F., Luger, K., Hansen, J. C. & Tremethick, D. J. The essential histone variant H2A.Z regulates the equilibrium between different chromatin conformational states. Nat. Struct. Biol. 9, 172–176 (2002).
pubmed: 11850638 doi: 10.1038/nsb0402-316b
Thambirajah, A. A. et al. H2A.Z stabilizes chromatin in a way that is dependent on core histone acetylation. J. Biol. Chem. 281, 20036–20044 (2006).
pubmed: 16707487 doi: 10.1074/jbc.M601975200
Carruthers, L. M., Bednar, J., Woodcock, C. L. & Hansen, J. C. Linker histones stabilize the intrinsic salt-dependent folding of nucleosomal arrays: mechanistic ramifications for higher-order chromatin folding. Biochemistry 37, 14776–14787 (1998).
pubmed: 9778352 doi: 10.1021/bi981684e
Zhou, J., Fan, J. Y., Rangasamy, D. & Tremethick, D. J. The nucleosome surface regulates chromatin compaction and couples it with transcriptional repression. Nat. Struct. Mol. Biol. 14, 1070–1076 (2007).
pubmed: 17965724 doi: 10.1038/nsmb1323
Mylonas, C., Lee, C., Auld, A. L., Cisse, I. I. & Boyer, L. A. A dual role for H2A.Z.1 in modulating the dynamics of RNA polymerase II initiation and elongation. Nat. Struct. Mol. Biol. 28, 435–442 (2021).
pubmed: 33972784 doi: 10.1038/s41594-021-00589-3
Chen, Z. et al. High-resolution and high-accuracy topographic and transcriptional maps of the nucleosome barrier. Elife 8, e48281 (2019).
Abbott, D. W., Ivanova, V. S., Wang, X., Bonner, W. M. & Ausio, J. Characterization of the stability and folding of H2A.Z chromatin particles: implications for transcriptional activation. J. Biol. Chem. 276, 41945–41949 (2001).
pubmed: 11551971 doi: 10.1074/jbc.M108217200
Henikoff, S. Labile H3.3+H2A.Z nucleosomes mark ‘nucleosome-free regions. Nat. Genet. 41, 865–866 (2009).
pubmed: 19639024 doi: 10.1038/ng0809-865
Jin, C. et al. H3.3/H2A.Z double variant-containing nucleosomes mark ‘nucleosome-free regions’ of active promoters and other regulatory regions. Nat. Genet. 41, 941–945 (2009).
pubmed: 19633671 pmcid: 3125718 doi: 10.1038/ng.409
Rudnizky, S. et al. H2A.Z controls the stability and mobility of nucleosomes to regulate expression of the LH genes. Nat. Commun. 7, 12958 (2016).
pubmed: 27653784 pmcid: 5036153 doi: 10.1038/ncomms12958
Hu, G. et al. H2A.Z facilitates access of active and repressive complexes to chromatin in embryonic stem cell self-renewal and differentiation. Cell Stem Cell 12, 180–192 (2013).
pubmed: 23260488 doi: 10.1016/j.stem.2012.11.003
Hainer, S. J. & Fazzio, T. G. Regulation of Nucleosome Architecture and Factor Binding Revealed by Nuclease Footprinting of the ESC Genome. Cell Rep. 13, 61–69 (2015).
pubmed: 26411677 pmcid: 4598306 doi: 10.1016/j.celrep.2015.08.071
Murphy, K. E., Meng, F. W., Makowski, C. E. & Murphy, P. J. Genome-wide chromatin accessibility is restricted by ANP32E. Nat. Commun. 11, 5063 (2020).
pubmed: 33033242 pmcid: 7546623 doi: 10.1038/s41467-020-18821-x
Wen, Z., Zhang, L., Ruan, H. & Li, G. Histone variant H2A.Z regulates nucleosome unwrapping and CTCF binding in mouse ES cells. Nucleic Acids Res. 48, 5939–5952 (2020).
pubmed: 32392318 pmcid: 7293034 doi: 10.1093/nar/gkaa360
Hoch, D. A., Stratton, J. J. & Gloss, L. M. Protein-protein Forster resonance energy transfer analysis of nucleosome core particles containing H2A and H2A.Z. J. Mol. Biol. 371, 971–988 (2007).
pubmed: 17597150 pmcid: 2031861 doi: 10.1016/j.jmb.2007.05.075
Lewis, T. S., Sokolova, V., Jung, H., Ng, H. & Tan, D. Structural basis of chromatin regulation by histone variant H2A.Z. Nucleic Acids Res. 49, 11379–11391 (2021).
pubmed: 34643712 pmcid: 8565303 doi: 10.1093/nar/gkab907
Jung, H., Sokolova, V., Lee, G., Stevens, V. R. & Tan, D. Structural and biochemical characterization of the nucleosome containing variants H3.3 and H2A.Z. Epigenomes 8, 21 (2024).
Cole, L. et al. Multiple roles of H2A.Z in regulating promoter chromatin architecture in human cells. Nat. Commun. 12, 2524 (2021).
pubmed: 33953180 pmcid: 8100287 doi: 10.1038/s41467-021-22688-x
Sarcinella, E., Zuzarte, P. C., Lau, P. N., Draker, R. & Cheung, P. Monoubiquitylation of H2A.Z distinguishes its association with euchromatin or facultative heterochromatin. Mol. Cell. Biol. 27, 6457–6468 (2007).
pubmed: 17636032 pmcid: 2099601 doi: 10.1128/MCB.00241-07
Ryan, D. P. & Tremethick, D. J. The interplay between H2A.Z and H3K9 methylation in regulating HP1alpha binding to linker histone-containing chromatin. Nucleic Acids Res. 46, 9353–9366 (2018).
pubmed: 30007360 pmcid: 6182156 doi: 10.1093/nar/gky632
Oberdoerffer, P. & Miller, K. M. Histone H2A variants: diversifying chromatin to ensure genome integrity. Semin. Cell Dev. Biol. 135, 59–72 (2023).
pubmed: 35331626 doi: 10.1016/j.semcdb.2022.03.011
Matsuda, R. et al. Identification and characterization of the two isoforms of the vertebrate H2A.Z histone variant. Nucleic Acids Res. 38, 4263–4273 (2010).
pubmed: 20299344 pmcid: 2910051 doi: 10.1093/nar/gkq171
Faast, R. et al. Histone variant H2A.Z is required for early mammalian development. Curr. Biol.: CB 11, 1183–1187 (2001).
pubmed: 11516949 doi: 10.1016/S0960-9822(01)00329-3
Greenberg, R. S., Long, H. K., Swigut, T. & Wysocka, J. Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome. Cell 178, 1421–1436.e1424 (2019).
pubmed: 31491386 pmcid: 7103420 doi: 10.1016/j.cell.2019.08.002
Cheema, M. S. et al. Deciphering the enigma of the histone H2A.Z-1/H2A.Z-2 isoforms: novel insights and remaining questions. Cells 9, 1167 (2020).
Sales-Gil, R. et al. Non-redundant functions of H2A.Z.1 and H2A.Z.2 in chromosome segregation and cell cycle progression. EMBO Rep. 22, e52061 (2021).
pubmed: 34423893 pmcid: 8567233 doi: 10.15252/embr.202052061
Suto, R. K., Clarkson, M. J., Tremethick, D. J. & Luger, K. Crystal structure of a nucleosome core particle containing the variant histone H2A.Z. Nat. Struct. Biol. 7, 1121–1124 (2000).
pubmed: 11101893 doi: 10.1038/81971
Bonisch, C. et al. H2A.Z.2.2 is an alternatively spliced histone H2A.Z variant that causes severe nucleosome destabilization. Nucleic Acids Res. 40, 5951–5964 (2012).
pubmed: 22467210 pmcid: 3401452 doi: 10.1093/nar/gks267
Herchenrother, A., Wunderlich, T. M., Lan, J. & Hake, S. B. Spotlight on histone H2A variants: from B to X to Z. Semin. Cell Dev. Biol. 135, 3–12 (2023).
pubmed: 35365397 doi: 10.1016/j.semcdb.2022.03.025
Morioka, S. et al. High-speed atomic force microscopy reveals spontaneous nucleosome sliding of H2A.Z at the subsecond time scale. Nano Lett. 23, 1696–1704 (2023).
pubmed: 36779562 doi: 10.1021/acs.nanolett.2c04346
Imre, L. et al. Nucleosome stability measured in situ by automated quantitative imaging. Sci. Rep. 7, 12734 (2017).
pubmed: 28986581 pmcid: 5630628 doi: 10.1038/s41598-017-12608-9
Kusakabe, M. et al. Genetic complementation analysis showed distinct contributions of the N-terminal tail of H2A.Z to epigenetic regulations. Genes Cells 21, 122–135 (2016).
pubmed: 26833946 doi: 10.1111/gtc.12327
Punzeler, S. et al. Multivalent binding of PWWP2A to H2A.Z regulates mitosis and neural crest differentiation. EMBO J. 36, 2263–2279 (2017).
pubmed: 28645917 pmcid: 5538766 doi: 10.15252/embj.201695757
Li, W., Nagaraja, S., Delcuve, G. P., Hendzel, M. J. & Davie, J. R. Effects of histone acetylation, ubiquitination and variants on nucleosome stability. Biochem. J. 296, 737–744 (1993).
pubmed: 8280071 pmcid: 1137757 doi: 10.1042/bj2960737
Nmezi, B. et al. Concentric organization of A- and B-type lamins predicts their distinct roles in the spatial organization and stability of the nuclear lamina. Proc. Natl Acad. Sci. USA 116, 4307–4315 (2019).
pubmed: 30765529 pmcid: 6410836 doi: 10.1073/pnas.1810070116
Cheema, M. S. & Ausio, J. Analytical ultracentrifuge analysis of nucleosomes assembled from recombinant, acid-extracted, HPLC-purified histones. Methods Mol. Biol. 1528, 75–95 (2017).
pubmed: 27854017 doi: 10.1007/978-1-4939-6630-1_6
Dryhurst, D. et al. Characterization of the histone H2A.Z-1 and H2A.Z-2 isoforms in vertebrates. BMC Biol. 7, 86 (2009).
pubmed: 20003410 pmcid: 2805615 doi: 10.1186/1741-7007-7-86
Fyodorov, D. V., Zhou, B. R., Skoultchi, A. I. & Bai, Y. Emerging roles of linker histones in regulating chromatin structure and function. Nat. Rev. Mol. Cell Biol. 19, 192–206 (2018).
pubmed: 29018282 doi: 10.1038/nrm.2017.94
Douet, J. et al. MacroH2A histone variants maintain nuclear organization and heterochromatin architecture. J. Cell Sci. 130, 1570–1582 (2017).
pubmed: 28283545 doi: 10.1242/jcs.199216
Skene, P. J. & Henikoff, S. An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. Elife 6, (2017).
Zhou, M. et al. Structural basis of nucleosome dynamics modulation by histone variants H2A.B and H2A.Z.2.2. EMBO J. 40, e105907 (2021).
pubmed: 33073403 doi: 10.15252/embj.2020105907
Gursoy-Yuzugullu, O., Ayrapetov, M. K. & Price, B. D. Histone chaperone Anp32e removes H2A.Z from DNA double-strand breaks and promotes nucleosome reorganization and DNA repair. Proc. Natl Acad. Sci. USA 112, 7507–7512 (2015).
pubmed: 26034280 pmcid: 4475971 doi: 10.1073/pnas.1504868112
Mieczkowski, J. et al. MNase titration reveals differences between nucleosome occupancy and chromatin accessibility. Nat. Commun. 7, 11485 (2016).
pubmed: 27151365 pmcid: 4859066 doi: 10.1038/ncomms11485
Chereji, R. V., Bryson, T. D. & Henikoff, S. Quantitative MNase-seq accurately maps nucleosome occupancy levels. Genome Biol. 20, 198 (2019).
pubmed: 31519205 pmcid: 6743174 doi: 10.1186/s13059-019-1815-z
Becker, J. S. et al. Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes. Mol. Cell 68, 1023–1037 e1015 (2017).
pubmed: 29272703 pmcid: 5858919 doi: 10.1016/j.molcel.2017.11.030
Mazouchi, A., Liu, B., Bahram, A. & Gradinaru, C. C. On the performance of bioanalytical fluorescence correlation spectroscopy measurements in a multiparameter photon-counting microscope. Anal. Chim. Acta 688, 61–69 (2011).
pubmed: 21296206 doi: 10.1016/j.aca.2011.01.002
Gansen, A. et al. High precision FRET studies reveal reversible transitions in nucleosomes between microseconds and minutes. Nat. Commun. 9, 4628 (2018).
pubmed: 30401903 pmcid: 6219519 doi: 10.1038/s41467-018-06758-1
Vardabasso, C. et al. Histone variant H2A.Z.2 mediates proliferation and drug sensitivity of malignant melanoma. Mol. Cell 59, 75–88 (2015).
pubmed: 26051178 pmcid: 4490946 doi: 10.1016/j.molcel.2015.05.009
Saeed, S. et al. Chromatin accessibility, p300, and histone acetylation define PML-RARalpha and AML1-ETO binding sites in acute myeloid leukemia. Blood 120, 3058–3068 (2012).
pubmed: 22923494 doi: 10.1182/blood-2011-10-386086
Achinger-Kawecka, J. et al. Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer. Nat. Commun. 11, 320 (2020).
pubmed: 31949157 pmcid: 6965612 doi: 10.1038/s41467-019-14098-x
Oomen, M. E., Hansen, A. S., Liu, Y., Darzacq, X. & Dekker, J. CTCF sites display cell cycle-dependent dynamics in factor binding and nucleosome positioning. Genome Res. 29, 236–249 (2019).
pubmed: 30655336 pmcid: 6360813 doi: 10.1101/gr.241547.118
Sevilla, A. & Binda, O. Post-translational modifications of the histone variant H2AZ. Stem Cell Res. 12, 289–295 (2014).
pubmed: 24316985 doi: 10.1016/j.scr.2013.11.004
Colino-Sanguino, Y. et al. A read/write mechanism connects p300 bromodomain function to H2A.Z acetylation. iScience 21, 773–788 (2019).
pubmed: 31727574 pmcid: 6889796 doi: 10.1016/j.isci.2019.10.053
Giaimo, B. D., Ferrante, F., Herchenrother, A., Hake, S. B. & Borggrefe, T. The histone variant H2A.Z in gene regulation. Epigenetics Chromatin 12, 37 (2019).
pubmed: 31200754 pmcid: 6570943 doi: 10.1186/s13072-019-0274-9
Foster, E. R. & Downs, J. A. Methylation of H3 K4 and K79 is not strictly dependent on H2B K123 ubiquitylation. J. Cell Biol. 184, 631–638 (2009).
pubmed: 19255247 pmcid: 2686411 doi: 10.1083/jcb.200812088
Li, S., Wei, T. & Panchenko, A. R. Histone variant H2A.Z modulates nucleosome dynamics to promote DNA accessibility. Nat. Commun. 14, 769 (2023).
pubmed: 36765119 pmcid: 9918499 doi: 10.1038/s41467-023-36465-5
Arya, G. & Schlick, T. A tale of tails: how histone tails mediate chromatin compaction in different salt and linker histone environments. J. Phys. Chem. A 113, 4045–4059 (2009).
pubmed: 19298048 pmcid: 2693032 doi: 10.1021/jp810375d
Flaus, A. Principles and practice of nucleosome positioning in vitro. Front. Life Sci. 5, 27–25 (2011).
doi: 10.1080/21553769.2012.702667
Pilotto, S. et al. Interplay among nucleosomal DNA, histone tails, and corepressor CoREST underlies LSD1-mediated H3 demethylation. Proc. Natl Acad. Sci. USA 112, 2752–2757 (2015).
pubmed: 25730864 pmcid: 4352788 doi: 10.1073/pnas.1419468112
Luzhetskaya, O. P., Sedykh, S. E. & Nevinsky, G. A. How human H1 histone recognizes DNA. Molecules 25, 4556 (2020).
Bosire, R. et al. Intercalation of small molecules into DNA in chromatin is primarily controlled by superhelical constraint. PLoS ONE 14, e0224936 (2019).
pubmed: 31747397 pmcid: 6867626 doi: 10.1371/journal.pone.0224936
Wang, A. Y., Aristizabal, M. J., Ryan, C., Krogan, N. J. & Kobor, M. S. Key functional regions in the histone variant H2A.Z C-terminal docking domain. Mol. Cell. Biol. 31, 3871–3884 (2011).
pubmed: 21791612 pmcid: 3165728 doi: 10.1128/MCB.05182-11
Lee, S. K. & Wang, W. Roles of topoisomerases in heterochromatin, aging, and diseases. Genes 10, 884 (2019).
Holmquist, G., Gray, M., Porter, T. & Jordan, J. Characterization of Giemsa dark- and light-band DNA. Cell 31, 121–129 (1982).
pubmed: 7159923 doi: 10.1016/0092-8674(82)90411-1
Long, H. et al. H2A.Z facilitates licensing and activation of early replication origins. Nature 577, 576–581 (2020).
pubmed: 31875854 doi: 10.1038/s41586-019-1877-9
Saitoh, Y. & Laemmli, U. K. Metaphase chromosome structure: bands arise from a differential folding path of the highly AT-rich scaffold. Cell 76, 609–622 (1994).
pubmed: 7510215 doi: 10.1016/0092-8674(94)90502-9
Dijkwel, Y., Hart-Smith, G., Kurscheid, S. & Tremethick, D. J. ANP32e binds histone H2A.Z in a cell cycle-dependent manner and regulates its protein stability in the cytoplasm. Mol. Cell. Biol. 44, 72–85 (2024).
pubmed: 38482865 pmcid: 10950284 doi: 10.1080/10985549.2024.2319731
Kimura, H. & Cook, P. R. Kinetics of core histones in living human cells: little exchange of H3 and H4 and some rapid exchange of H2B. J. cell Biol. 153, 1341–1353 (2001).
pubmed: 11425866 pmcid: 2150718 doi: 10.1083/jcb.153.7.1341
Kimura, H., Hayashi-Takanaka, Y., Goto, Y., Takizawa, N. & Nozaki, N. The organization of histone H3 modifications as revealed by a panel of specific monoclonal antibodies. Cell Struct. Funct. 33, 61–73 (2008).
pubmed: 18227620 doi: 10.1247/csf.07035
Hayashi-Takanaka, Y. et al. Tracking epigenetic histone modifications in single cells using Fab-based live endogenous modification labeling. Nucleic Acids Res. 39, 6475–6488 (2011).
pubmed: 21576221 pmcid: 3159477 doi: 10.1093/nar/gkr343
Afgan, E. et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 46, W537–W544 (2018).
pubmed: 29790989 pmcid: 6030816 doi: 10.1093/nar/gky379
Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008).
pubmed: 19029910 doi: 10.1038/nbt.1511
Meers, M. P., Bryson, T. D., Henikoff, J. G. & Henikoff, S. Improved CUT&RUN chromatin profiling tools. Elife 8, e46314 (2019).
Tremethick, D. J. High mobility group proteins 14 and 17 can space nucleosomal particles deficient in histones H2A and H2B creating a template that is transcriptionally active. J. Biol. Chem. 269, 28436–28442 (1994).
pubmed: 7961785 doi: 10.1016/S0021-9258(18)46946-3
Toth, K., Brun, N. & Langowski, J. Chromatin compaction at the mononucleosome level. Biochemistry 45, 1591–1598 (2006).
pubmed: 16460006 doi: 10.1021/bi052110u
Gansen, A. et al. Nucleosome disassembly intermediates characterized by single-molecule FRET. Proc. Natl Acad. Sci. USA 106, 15308–15313 (2009).
pubmed: 19706432 pmcid: 2741247 doi: 10.1073/pnas.0903005106
Enderlein, J., Gregor, I., Patra, D., Dertinger, T. & Kaupp, U. B. Performance of fluorescence correlation spectroscopy for measuring diffusion and concentration. ChemPhysChem 6, 2324–2336 (2005).
pubmed: 16273566 doi: 10.1002/cphc.200500414

Auteurs

László Imre (L)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Péter Nánási (P)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Ibtissem Benhamza (I)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Kata Nóra Enyedi (KN)

Department of Organic Chemistry, Institute of Chemistry, Eötvös Loránd University, Budapest, Hungary.
HUN-REN-ELTE, Supported Research Groups, Research Group of Peptide Chemistry, Budapest, Hungary.

Gábor Mocsár (G)

Damjanovich Cell Analysis Core Facility, Department of Biophysics and Cell Biology, University of Debrecen, Faculty of Medicine, Debrecen, Hungary.

Rosevalentine Bosire (R)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Éva Hegedüs (É)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Erfaneh Firouzi Niaki (EF)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Ágota Csóti (Á)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Zsuzsanna Darula (Z)

Single Cell Omics Advanced Core Facility, Hungarian Centre of Excellence for Molecular Medicine, Szeged, Hungary.
Core Facility, Proteomics Research Group, HUN-REN Biological Research Centre, Szeged, Hungary.

Éva Csősz (É)

Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, H-4032, Hungary.

Szilárd Póliska (S)

Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, H-4032, Hungary.

Beáta Scholtz (B)

Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, H-4032, Hungary.

Gábor Mező (G)

Department of Organic Chemistry, Institute of Chemistry, Eötvös Loránd University, Budapest, Hungary.
HUN-REN-ELTE, Supported Research Groups, Research Group of Peptide Chemistry, Budapest, Hungary.

Zsolt Bacsó (Z)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

H T Marc Timmers (HTM)

German Cancer Consortium (DKTK), partner site Freiburg, a partnership between the DKFZ and Medical Center-University of Freiburg and Department of Urology, Medical Center-University of Freiburg, Breisacher Str. 66, Freiburg, Germany.

Masayuki Kusakabe (M)

Biosignal Research Center, Kobe University, 1-1 Rokkodai-cho, Nada-ku, Kobe, 657-8501, Japan.

Margit Balázs (M)

HUN-REN-UD Public Health Research Group, Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

György Vámosi (G)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Juan Ausio (J)

Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.

Peter Cheung (P)

York University, Toronto, Canada.

Katalin Tóth (K)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

David Tremethick (D)

The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia.

Masahiko Harata (M)

Laboratory of Molecular Biology, Graduate School of Agricultural Science, Tohoku University, Sendai, Japan.

Gábor Szabó (G)

Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. szabog@med.unideb.hu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH